FDA Inspection 1117803 — AcelRx Pharmaceuticals, Inc.
The FDA completed an inspection of AcelRx Pharmaceuticals, Inc. on February 13, 2020 in Hayward, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- February 13, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Hayward, CA (United States)
Additional Details
Risk Evaluation and Mitigation Strategies (REMS)